- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
49
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
49 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
2653 | CN¥33.60 | 2.9% | 44.7% | CN¥37.1b | CN¥34.94 | PE96.4x | E37.8% | 0.9% | ||
TARSONS | ₹438.95 | -8.5% | -16.5% | ₹23.4b | ₹551.25 | PE63x | E27.5% | 0.5% | ||
524164 | ₹476.05 | -2.1% | -0.08% | ₹28.7b | ₹471.00 | PE23.6x | E22.2% | 1.1% | ||
4974 | JP¥1,042.00 | 1.9% | -24.7% | JP¥125.5b | JP¥1,533.33 | PE1100.6x | E30.2% | 1.6% | ||
RJF | €2.75 | -1.1% | 12.2% | €220.2m | n/a | PE23.8x | E24.4% | 1.5% | ||
301333 | CN¥43.75 | 16.1% | -38.6% | CN¥4.2b | CN¥55.00 | PE31.1x | E26.7% | 0.5% | ||
300347 | CN¥59.30 | 18.2% | -11.0% | CN¥47.7b | CN¥68.90 | PE45.2x | E25.9% | 1.0% | ||
ORCHPHARMA | ₹1,424.55 | 2.3% | 167.9% | ₹72.3b | ₹1,525.33 | PE64.4x | E43.7% | n/a | ||
3020 | CN¥18.31 | 7.4% | -23.1% | CN¥3.5b | n/a | PE20.3x | E23.0% | 2.3% | ||
A237690 | ₩100,100.00 | -14.4% | 31.0% | ₩2.0t | ₩127,444.44 | PE92.5x | E37.4% | 0.5% | ||
301080 | CN¥37.26 | 18.2% | -46.9% | CN¥4.5b | CN¥46.93 | PE37.6x | E28.0% | 2.4% | ||
SHC | US$16.76 | 0.6% | 11.9% | US$4.7b | US$16.36 | PE118.9x | E48.2% | n/a | ||
A009420 | ₩37,500.00 | -1.3% | 14.9% | ₩1.9t | ₩51,000.00 | PS14.6x | E92.6% | n/a | ||
MLAB | US$127.72 | -0.7% | 21.6% | US$690.5m | US$130.00 | PS3.1x | E125.1% | 0.5% | ||
300896 | CN¥196.33 | 42.0% | -29.6% | CN¥59.1b | CN¥264.39 | PE29.3x | E22.3% | 0% | ||
FYB | €52.70 | 4.6% | -6.7% | €930.5m | €84.78 | PE14.6x | E30.5% | n/a | ||
ADMA | US$19.44 | -1.5% | 449.2% | US$4.5b | US$19.00 | PE130.2x | E26.0% | n/a | ||
688073 | CN¥32.57 | 11.2% | -54.8% | CN¥2.9b | CN¥40.00 | PE37.1x | E25.2% | 2.8% | ||
BLFS | US$24.34 | -5.5% | 76.2% | US$1.1b | US$28.67 | PS8x | E72.5% | n/a | ||
RGEN | US$145.93 | 2.1% | -8.2% | US$8.2b | US$193.82 | PS13.6x | E91.8% | n/a | ||
LLY | US$877.79 | -4.7% | 63.4% | US$818.8b | US$995.42 | PE107.6x | E28.5% | 0.6% | ||
BGNE | US$218.42 | 8.1% | 21.4% | US$22.6b | US$274.14 | PS7.5x | E64.1% | n/a | ||
2070 | ر.س34.15 | 0.6% | -3.3% | ر.س4.1b | ر.س33.36 | PS2.6x | E38.8% | 0% | ||
603566 | CN¥12.97 | 17.1% | -39.1% | CN¥4.5b | CN¥16.24 | PE33.7x | E27.8% | 6.2% |